Matches in SemOpenAlex for { <https://semopenalex.org/work/W62932030> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W62932030 endingPage "64" @default.
- W62932030 startingPage "459" @default.
- W62932030 abstract "Eflornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase, and mitoguazone (MGBG), a competitive inhibitor of S-adenosylmethionine decarboxylase, were evaluated in a phase I-II study for patients with primary recurrent malignant brain tumors. All patients had failed prior radiation therapy and most had also failed prior chemotherapy. Two dose schedules were used, with the second schedule (Group II) a modification of the first schedule (Group I). The Group II schedule, with different dose levels, was better tolerated than the Group I schedule. Gastrointestinal and myelotoxicity were dose-limiting in most patients, and tinnitus was dose-limiting in two patients. Nineteen of 33 evaluable patients had anaplastic gliomas, in whom response was observed in 21%, stable disease in 53%, and immediate progression after one course of therapy in 26%. Of six patients with glioblastoma multiforme, two had brief stabilization of disease. An additional patient with brainstem glioma and ependymoma also had disease stabilization. Four patients with medulloblastoma, a spinal cord mixed glioma, and one with oligodendroglioma failed DFMO-MGBG. Based on this study, we believe that a combination of DFMO and MGBG is well-tolerated and deserves further evaluation for patients with anaplastic gliomas, particularly those that appear to be biologically slow growing." @default.
- W62932030 created "2016-06-24" @default.
- W62932030 creator A5004126746 @default.
- W62932030 creator A5014104560 @default.
- W62932030 creator A5015863800 @default.
- W62932030 creator A5028023803 @default.
- W62932030 creator A5044634523 @default.
- W62932030 creator A5046264008 @default.
- W62932030 creator A5057936028 @default.
- W62932030 creator A5068901913 @default.
- W62932030 creator A5076054133 @default.
- W62932030 creator A5087263869 @default.
- W62932030 date "1987-05-01" @default.
- W62932030 modified "2023-09-26" @default.
- W62932030 title "Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors." @default.
- W62932030 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3105881" @default.
- W62932030 hasPublicationYear "1987" @default.
- W62932030 type Work @default.
- W62932030 sameAs 62932030 @default.
- W62932030 citedByCount "15" @default.
- W62932030 countsByYear W629320302018 @default.
- W62932030 countsByYear W629320302022 @default.
- W62932030 crossrefType "journal-article" @default.
- W62932030 hasAuthorship W62932030A5004126746 @default.
- W62932030 hasAuthorship W62932030A5014104560 @default.
- W62932030 hasAuthorship W62932030A5015863800 @default.
- W62932030 hasAuthorship W62932030A5028023803 @default.
- W62932030 hasAuthorship W62932030A5044634523 @default.
- W62932030 hasAuthorship W62932030A5046264008 @default.
- W62932030 hasAuthorship W62932030A5057936028 @default.
- W62932030 hasAuthorship W62932030A5068901913 @default.
- W62932030 hasAuthorship W62932030A5076054133 @default.
- W62932030 hasAuthorship W62932030A5087263869 @default.
- W62932030 hasConcept C121289238 @default.
- W62932030 hasConcept C126322002 @default.
- W62932030 hasConcept C141071460 @default.
- W62932030 hasConcept C142724271 @default.
- W62932030 hasConcept C143998085 @default.
- W62932030 hasConcept C181199279 @default.
- W62932030 hasConcept C185592680 @default.
- W62932030 hasConcept C2776694085 @default.
- W62932030 hasConcept C2776755627 @default.
- W62932030 hasConcept C2777931997 @default.
- W62932030 hasConcept C2778227246 @default.
- W62932030 hasConcept C2778880634 @default.
- W62932030 hasConcept C2779429289 @default.
- W62932030 hasConcept C2779434656 @default.
- W62932030 hasConcept C2780722877 @default.
- W62932030 hasConcept C2780789225 @default.
- W62932030 hasConcept C2781432949 @default.
- W62932030 hasConcept C502942594 @default.
- W62932030 hasConcept C55493867 @default.
- W62932030 hasConcept C71924100 @default.
- W62932030 hasConcept C90924648 @default.
- W62932030 hasConceptScore W62932030C121289238 @default.
- W62932030 hasConceptScore W62932030C126322002 @default.
- W62932030 hasConceptScore W62932030C141071460 @default.
- W62932030 hasConceptScore W62932030C142724271 @default.
- W62932030 hasConceptScore W62932030C143998085 @default.
- W62932030 hasConceptScore W62932030C181199279 @default.
- W62932030 hasConceptScore W62932030C185592680 @default.
- W62932030 hasConceptScore W62932030C2776694085 @default.
- W62932030 hasConceptScore W62932030C2776755627 @default.
- W62932030 hasConceptScore W62932030C2777931997 @default.
- W62932030 hasConceptScore W62932030C2778227246 @default.
- W62932030 hasConceptScore W62932030C2778880634 @default.
- W62932030 hasConceptScore W62932030C2779429289 @default.
- W62932030 hasConceptScore W62932030C2779434656 @default.
- W62932030 hasConceptScore W62932030C2780722877 @default.
- W62932030 hasConceptScore W62932030C2780789225 @default.
- W62932030 hasConceptScore W62932030C2781432949 @default.
- W62932030 hasConceptScore W62932030C502942594 @default.
- W62932030 hasConceptScore W62932030C55493867 @default.
- W62932030 hasConceptScore W62932030C71924100 @default.
- W62932030 hasConceptScore W62932030C90924648 @default.
- W62932030 hasIssue "5" @default.
- W62932030 hasLocation W629320301 @default.
- W62932030 hasOpenAccess W62932030 @default.
- W62932030 hasPrimaryLocation W629320301 @default.
- W62932030 hasRelatedWork W2050857172 @default.
- W62932030 hasRelatedWork W2054008043 @default.
- W62932030 hasRelatedWork W2072667970 @default.
- W62932030 hasRelatedWork W2118249564 @default.
- W62932030 hasRelatedWork W2372963302 @default.
- W62932030 hasRelatedWork W2374622150 @default.
- W62932030 hasRelatedWork W2388522315 @default.
- W62932030 hasRelatedWork W2424807616 @default.
- W62932030 hasRelatedWork W2460554367 @default.
- W62932030 hasRelatedWork W62932030 @default.
- W62932030 hasVolume "71" @default.
- W62932030 isParatext "false" @default.
- W62932030 isRetracted "false" @default.
- W62932030 magId "62932030" @default.
- W62932030 workType "article" @default.